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Cytokine-activated receptors undergo extracellular domain dimer-
ization, which is necessary to activate intracellular signaling path-
ways. Here, we report that in prolactin (PRL)-treated cells, PRL
receptor (PRLR) undergoes cytoplasmic loop dimerization that is
acetylation-dependent. PRLR-recruited CREB-binding protein (CBP)
acetylates multiple lysine sites randomly distributed along the
cytoplasmic loop of PRLR. Two PRLR monomers appear to interact
with each other at multiple parts from the membrane-proximal
region to the membrane-distal region, relying on the coordination
amongmultiple lysine sites neutralized via acetylation. Cytoplasmic
loop-dimerized PRLR activates STAT5, which is also acetylated
by CBP and undergoes acetylation-dependent dimerization. PRLR
dimerization and subsequent signaling are enhanced by treating
the cells with deacetylase sirtuin (SIRT) inhibitor nicotinamide or
histone deacetylase (HDAC) inhibitor trichostatin A but inhibited by
expressing exogenous deacetylase SIRT2 or HDAC6. Our results
suggest that acetylation and deacetylation provide the rheostat-
like regulation for the cytokine receptor PRLR in its cytoplasmic loop
dimerization and subsequent STAT5 activation.
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Type I cytokine receptors share a common structure of an ex-tracellular ligand-binding domain bearing a conserved “WSXWS”
motif, a single transmembrane helix, and a cytoplasmic loop
(Table S1). Prolactin receptor (PRLR) is an essential type I cy-
tokine receptor involved in mammary gland development during
pregnancy and lactation. On ligand binding, the membrane-
proximal regions of the PRLR cytoplasmic loop are brought
into deﬁned proximity to ensure activation of the protein kinase
JAK2, which docks within the membrane-proximal proline box
(1, 2). JAK2 phosphorylates PRLR on multiple tyrosine sites
along the loop and the loop-associated STAT5a, and STAT5b on
a conserved tyrosine residue within the C-terminal SH2-di-
merization domain. Subsequently, tyrosine-phosphorylated STAT5
dissociates from the receptor, forms a transcriptional active dimer,
and translocates into the nucleus, where it regulates gene expres-
sion associated with the functions of the ligand prolactin (PRL).
Associated with one monomer of a dimer, JAK phosphorylates
STAT docked along the loop of the other receptor molecule of the
dimer, requiring a close proximity between two receptor molecules
in their cytoplasmic loops (3–5). The cytoplasmic loops of type I
cytokine receptors can be very different in size, ranging from 31 to
568 residues, with no apparent homology in primary sequences
(Table S1). Both the number and location of positively charged
lysine may affect two cytoplasmic loops to reach close proximity
during homodimerization.
Here, we show that PRL-activated PRLR and its downstream
STAT5b were both highly acetylated by CREB-binding protein
(CBP). By recruiting CBP, the PRLR cytoplasmic loop was acet-
ylated on multiple lysine sites along the loop that work together to
neutralize the positive charge of lysine side chain, weaken the elec-
trostatic resistance, andallow two receptormolecules to reach a close
proximity for homodimerization within their cytoplasmic loops.
PRLR-recruited STAT5b, conversely, was activated largely via K694
acetylation-dependent dimerization. Acetylation-dependent cy-
toplasmic loop dimerization has been shared as a mechanism
for activation among type I cytokine receptors that activate STAT.
Results
PRLR Is Acetylated by CBP on Multiple Sites Along Its Cytoplasmic
Loop. In human breast cancer T47D cells, PRL treatment induced
PRLR acetylation, which was moderately but repeatedly en-
hanced by pretreatment of the cells with the deacetylase sirtuin
(SIRT) inhibitor nicotinamide (NAM) (Fig. 1A and Fig. S1A).
PRL-induced PRLR acetylation in T47D cells was largely abol-
ished when CBP was depleted by transient transfection with
speciﬁc siRNA (Fig. 1B). CBP-mediated acetylation of PRLRwas
reversed if the deacetylase SIRT2 or, to a lesser extent, SIRT1 or
histone deacetylase (HDAC) family member HDAC6 or HDAC3
was overexpressed (Fig. 1C and Fig. S1B). Treating the trans-
fectants with NAM or the HDAC inhibitor trichostatin A (TSA)
could moderately but repeatedly elevate PRLR acetylation (Fig.
1C). Among the histone acetyltransferases (HATs) tested in
a transient transfection analysis, CBP or, to a much lesser extent,
p300 overexpression catalyzed PRLR acetylation in human em-
bryonic kidney 293T cells (Fig. S1C). To narrow down the acet-
ylation regions, we generated a series of Myc-tagged PRLR
cytoplasmic loop truncates that lack the extracellular and trans-
membrane domains (Fig. S1D) and examined their acetylation by
CBP cotransfection in 293T cells. The acetylation intensity re-
duced proportionally when the cytoplasmic loop was propor-
tionally truncated (Fig. 1D). CBP appeared to acetylate the
PRLR cytoplasmic loop in multiple regions from the C terminus
to the membrane-proximal region. Hence, PRLR can be acety-
lated by CBP, a process that can be reversed by both SIRT type
and HDAC type deacetylases in cells.
To map acetylated lysine sites, CBP-acetylated PRLR was
immunopuriﬁed from 293T transfectants and submitted to MS
analysis. Fifteen lysine residues (i.e., K277, K339, K412, K456,
K466, K472, K505, K514, K517, K526, K533, K536, K567, K590,
and K601) were identiﬁed as acetylation sites (Fig. S1F and
Table S2). These acetyl-lysine sites exclusively but randomly
distribute within the cytoplasmic loop of PRLR from the 259–
622 region. To examine endogenous PRLR acetylation in re-
sponse to PRL treatment, we generated rabbit polyclonal anti-
bodies to three randomly selected acetylation sites (i.e., K277,
K505, and K526) of PRLR (Fig. S1E). In T47D cells, PRLR
acetylation on these three sites within 5 min of PRL treatment
was clearly detected with these speciﬁc antibodies on protein
immunoblotting (Fig. 1E). A direct effect of CBP on PRLR
acetylation was further conﬁrmed by performing an in vitro
PRLR acetylation assay in which immunopuriﬁed PRLR was
incubated with bacterially puriﬁed GST-CBP in acetylation re-
action buffer, followed by Western blotting with a speciﬁc anti-
body recognizing acetyl-K277 of PRLR (Fig. 1F).
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CBP Exports from Nuclei to Associate with PRLR in Cytoplasm. CBP is
a transcription cofactor localized mainly in the nuclei of quiescent
cells, but it undergoes cytoplasmic accumulation in the cells treated
with type I IFN (IFN-α) or with UV light (6, 7). In T47D cells, CBP
was recovered from anti-PRLR immunoprecipitates in a ligand
stimulation-dependent manner (Fig. 2A). In T47D cells or another
human breast cancer line (MCF-7) cells, a basal level of CBP in
cytoplasmwas detected (Fig. 2B). CBP started to increase its level in
cytoplasm by receiving PRL treatment for 5 min (Fig. 2 B and C),
which was independent of JAK tyrosine kinase activity because
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Fig. 1. PRLR cytoplasmic loop is acetylated by CBP. (A) T47D cells received no treatment, PRL treatment for 30 min, or NAM (5 mM) pretreatment for 5.5 h,
followed by PRL treatment for 30 min. Immunoprecipitated (IP) PRLR was analyzed for acetylated-PRLR (aK-PRLR) with polyclonal antibody to acetyl-lysine.
(B) In T47D cells, CBP-speciﬁc siRNA or control (Ctl) siRNA was transiently transfected, followed by PRL treatment for 30 min. PRLR acetylation was analyzed as
above. (C) PRLR was cotransfected with CBP in 293T cells, followed by no treatment or treatment with NAM or TSA (1 μM). To test PRLR deacetylation, PRLR
and CBP were transfected along with Flag-tagged SIRT1, SIRT2, HDAC6, or HDAC3 in 293T cells, followed by acetylation blotting analysis. (D) Myc-PRLR
cytoplasmic loop truncation variants (from K259 to a different C-terminal end as illustrated in Fig. S1D) were transfected along with CBP in 293T cells, fol-
lowed by monoclonal anti-acetyl-lysine blotting. (E) Endogenous PRLR was immunoprecipitated from T47D cells treated with PRL for different times for
acetylation analysis, with speciﬁc antibodies recognizing indicated acetylation sites of PRLR. (F) GST-CBP-HAT (amino acids 1,196–1,718)–catalyzed PRLR-CD
acetylation in vitro was detected with anti-acetyl-K277-PRLR.
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Fig. 2. CBP nuclear exportation
on PRL stimulation. (A) In T47D
cells treated with PRL for differ-
ent times (as indicated), CBP was
recovered from PRLR immuno-
precipitate (IP) for Western blot
analysis. (B) Cytosolic (Cyt) and
nuclear (Nuc) fractions were pre-
pared from T47D cells treated
with PRL for different times, as
indicated, and analyzed for the
localization of CBP, histone H1,
and IκBα. Dynamic CBP subcellular
localization was also analyzed
with the cytosolic and nuclear
fractions prepared from MCF7
cells receiving PRL treatment. (C)
CBP was immunostained with
monoclonal anti-CBP in T47D cells
treatedwithorwithout PRL for 60
min. (D) YFP-tagged CBP of WT,
NLS1 deletion (NLS1Δ), NSL2 de-
letion (NLS2Δ), or nuclear export
signal deletion (NESΔ) form was
transiently expressed in 293T
cells and visualized with a confo-
cal microscope. (E) Empty vector
(EV) and Myc-tagged PRLR cyto-
plasmic loop truncation mutants
were cotransfected with HA-CBP
and coimmunoprecipitated with
HA polyclonal antibody. (F) Mass
spectrum of the peptide-bearing
phospho-T539 of PRLR. (G) Immunoprecipitated PRLR from T47D cells treated with PRL for different times, as indicated, was analyzed byWestern blotting with
anti-pT539-PRLR. (H) Puriﬁed GST-CBP protein was incubated with whole-cell extracts prepared from 293T cells transfected with empty vector (EV) or PRLR-HA
(WT, T539A, and T539D). PRLR proteins were recovered from GST-CBP precipitates in Western blots. (I) Indicated GST-CBP domain proteins were puriﬁed from
bacteria and incubated with Myc-tagged PRLR cytoplasmic domain prepared from 293T transfectants. The CBP-precipitated PRLR cytoplasmic domain was
detected by blotting with anti-Myc.
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JAK2 depletion in T47D cells did not affect CBP nuclear expor-
tation in response to PRL treatment (Fig. S2A). CBP bears two
putative nuclear localization signal (NLS) sequences and one pu-
tative nuclear export signal (L40PDELIPNGELSL) (Fig. S2B).
Deletion mutation analysis revealed that NLS1 (P10NPKRAKLS)
but not NLS2 (N1591KKTNKNKS-SISRANKKKP) was necessary
for nuclear localization of ﬂuorescent-taggedCBP (Fig. 2D).NSL1-
deleted CBP basically maintained its catalytic activity in PRLR
acetylation (Fig. S2C).
Overexpression of the above Myc-tagged cytoplasmic loop
variants of PRLR along with HA-tagged CBP revealed that the
interaction between CBP and the PRLR cytoplasmic loop was
attenuated when the cytoplasmic domain truncation was extended
from the 525–566 region (Fig. 2E), indicating that the 525–566
region is relevant to CBP association. MS analysis revealed that
T539 of the proline box (PELPPTPP) within residues 525–566
of PRLR was phosphorylated (Fig. 2F). With the rabbit poly-
clonal antibody generated against T539-phosphorylated PRLR,
we detected PRLR phosphorylation on T539, which was inducible
by PRL treatment in T47D cells using a polyclonal antibody raised
to recognize T539 phosphorylated PRLR (Fig. 2G and Fig. S1E).
We then estimated whether T539 phosphorylation is involved in
CBP docking, because CBP can dock on the phosphoserines re-
siding within a proline-rich motif of IFN-αR2 (7). PRLR with
T539A but not T539D substitution reduced the association ability
of CBP as analyzed with both in vitro and in vivo assays (Fig. 2H
and Fig. S2D), suggesting that phospho-T539 may indeed provide
CBP as a docking site. To uncover the domain of CBP responsible
for PRLR interaction, GST-fusion proteins of CBP domains (Fig.
S2B) puriﬁed from bacteria were incubated with the cytoplasmic
loop of PRLR expressed in 293T cells. The PRLR cytoplasmic
loop appeared to associate with CBP within both the N-terminal
CH1 domain (amino acids 1–460) and the C-terminal CH3 do-
main (amino acids 1,801–2,000) (Fig. 2I). Given that NSL1 falls
within the PRLR-binding domain, NSL1 deletion might partially
affect its catalytic activity in PRLR acetylation induction (Fig.
S2C) by affecting the interaction between these two proteins.
PRLR Cytoplasmic Loop Acetylation on Multiple Sites Coordinates
Cytoplasmic Loop Dimerization. Cytokine receptors undergo di-
merization induced by the interaction of their extracellular
domains. In T47D cell extracts treated with disuccinimidyl sub-
erate, endogenous PRLR proteins were cross-linked into species
migrating in SDS/PAGE at the expected position for a dimer (Fig.
S3A). Under both conditions, PRL treatment enhanced PRLR
dimerization, although a basal level of PRLR dimerization was
visualized (Fig. S3A). The interaction between the cytoplasmic
loop and full-length PRLR was induced by treating the cells with
PRL, TSA, or NAM either alone or combined (Fig. 3A). Both
TSA and NAM induced PRLR cytoplasmic loop acetylation in
293T cells as detected with the speciﬁc antibody recognizing
K277-acetylated PRLR (Fig. 3A and Fig. S3B). In contrast, the
interaction between the PRLR cytoplasmic loop and full-length
PRLR was inhibited by transient overexpression of the deacety-
lase SIRT2 or HDAC6 (Fig. 3B) or by depleting CBP with siRNA
(Fig. 3C). Hence, PRLR cytoplasmic loop dimerization appears
to be inﬂuenced by reversible acetylation.
To uncover the regions and identify the lysine site(s) responsible
for PRLR cytoplasmic loop dimerization, we transfected HA-
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Fig. 3. Acetylation modulates PRLR cytoplasmic loop dimerization. (A) HA-
PRLR-Full-Length (FL) and Myc-PRLR-Cytoplasmic Domain (C) were cotrans-
fected in 293T cells, followed by no treatment or treatment with PRL, TSA,
NAM, PRL plus NAM, or PRL plus TSA for 30 min. Anti-Myc immunoprecipi-
tates (IP) were analyzed with anti-HA, anti-Myc, or anti-aK277-PRLR. (B) In
293T cells, HA-PRLR-FL and Myc-PRLR-C were cotransfected with empty
vector, Flag-SIRT2, or Flag-HDAC6, followed by no treatment or PRL treat-
ment for 30 min. The Myc immunoprecipitates were analyzed with anti-HA
in Western blots (C) CBP depletion with siRNA on PRLR-FL and PRLR-C di-
merization was analyzed with coimmunoprecipitation. (D) In 293T cells, HA-
PRLR-FL was cotransfected with Myc-PRLR-C truncates, followed by NAM and
PRL cotreatment. Anti-Myc immunoprecipitates were analyzed with anti-HA,
anti-aK277-PRLR, or anti-aK505-PRLR. (E) FRET images of the indicated pairs
of CFP-PRLR and YFP-PRLR expressed in CHO cells, followed by PRL treatment
or no treatment. Images of CFP and YFP ﬂuorescence for individual CHO cells
before and after YFP bleaching are shown in the upper two rows. The dis-
appearance of YFP ﬂuorescence after bleaching and the increase in CFP
ﬂuorescence for WT and K1–15A mutant but not for K1–15R mutant after
PRL treatment were observed. (Left) Merging of YFP before and after bleach
and CFP before and after bleach are shown in the third row. (Right) Ratios of
CFPpost/CFPpre are shown in the third row. (F) FRET efﬁciency (y axis) from
the indicated CFP/YFP-tagged constructs in CHO cells treated with or without
PRL. For pre- and postphotobleaching image sets of CFP, the cell of interest
was selected and the background values were subtracted from the donor
pre- and postbleaching. The spectrally corrected FRET efﬁciency (E) was
calculated using the equation E = 1 − (FCFP(d)Pre/FCFP(d)Post) (23), where
FCFP(d)Pre and FCFP(d)Post are the mean CFP emission intensity of pre- and
postphotobleaching. Data represent the mean ± SEM for three to six cells.
When compared with WT, (−), or PRL, *P < 0.05 for K1–3R, K4–6R, K1–6R,
K7–12R, K1–12R, and K13–15R; **P < 0.01 for K1–15R; NS (not signiﬁcant)
for K1–15A. (G) HA-tagged and Myc-tagged PRLR-FL of WT, K1–15R, or
K1–15A was cotransfected in pairs in 293T cells, followed by PRL treatment
for 30 min. Anti-Myc immunoprecipitates were analyzed with anti-HA for
PRLR dimerization.
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tagged full-length PRLR along with the above Myc-tagged PRLR
cytoplasmic loop truncates (Fig. S1D). The subsequent coimmu-
noprecipitation results in Fig. 3D revealed that the interaction
between the full-length PRLR and these PRLR cytoplasmic loop
truncates was overall dependent on PRL and NAM treatment,
although the interaction between truncates such as the 259–566
region and full-length PRLR became less dependent on PRL
and NAM treatment. The effect of the K→R mutation on the
protein-protein interaction between the PRLR cytoplasmic loop
and full-length PRLR was examined. However, individual K→R
substitution of all 15 acetylated lysine sites exhibited no apparent
defect in dimerization between the PRLR cytoplasmic loop
and full-length PRLR (Fig. S3C). These results indicate that two
PRLR protein molecules may interact with each other through
multiple regions within their cytoplasmic loops during dimerization
and may be modulated by acetylation on multiple sites.
To assess cytokine receptor dimerization in living cells, we used
FRET to measure the energy transfer between monomeric YFP
and monomeric CFP as a function of distance (8). We prepared
two PRLR constructs with the CFP tag and YFP tag fused to the
C-terminal end of PRLR (i.e., PRLR-CFP and PRLR-YFP, re-
spectively). CHO cells were used for human PRLR FRET anal-
ysis because these cells do not respond to human PRL unless
exogenous PRLR of human origin is transfected (9). Both CFP-
and YFP-tagged PRLR was observed to localize on the cell
membrane (Fig. 3E). Although a high FRET signal of WT PRLR
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Fig. 4. STAT5 dimerization requires acetylation. (A) Mass spectra of acetylated peptides recovered from STAT5b prepared from 293T cells transfected with
STAT5 and CBP. (B) STAT5b WT and STAT5b with a K→R mutation were transiently transfected along with CBP in 293T cells. Immunoprecipitated (IP) STAT5b
proteins were analyzed with pan–anti-acetyl-lysine. (C) STAT5 acetylation in T47D cells received PRL treatment for different times and was analyzed with
speciﬁc polyclonal antibodies against ak359-STAT5b, aK694-STAT5b, and aK701-STAT5b, respectively. (D) In T47D, CBP down-regulation with siRNA on STAT5
acetylation (pan–anti-acetyl-lysine) in response to PRL treatment for 30 min. (E) In PC3 cells, Myc-tagged and HA-tagged STAT5b (WT or Lysine-to-Arginine
(KR) mutant) was cotransfected, followed by treatment with or without PRL for 30 min. Anti-Myc immunoprecipitates were blotted with anti-HA. (F) In PC3
cells, empty vector (EV), STAT5b WT, or STAT5b KR mutants were transfected along with pLHRE-luciferase reporter, followed by treatment with PRL for 6–12
h before luciferase activity assay. (G) Myc-STAT5b was transfected along with EV, PRLR WT, or PRLR K1–15R in 293T cells, followed by PRL treatment for
30 min. Anti-Myc immunoprecipitates were analyzed with indicated antibodies. (H) 293T cells were transiently transfected with PRLR and JAK2, followed by
PRL treatment for 60 min. Immunoprecipitated JAK2 was analyzed for PRLR association or phospho-JAK2. (I) (Left) In 293T cells, PRLR WT and indicated PRLR
mutants were transfected along with pLHRE-luciferase reporter, followed by PRL treatment for 6–12 h before luciferase activity assay. In 293T cells, EV, CBP, or
SIRT2 was cotransfected with PRLR and luciferase reporter or siRNA of control (CTL), CBP, or SIRT was cotransfected with PRLR and luciferase reporter. (Right) Lu-
ciferase activity assay was performed under the same conditions as above.
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expressed as CFP and YFP forms in CHO cells was observed in
the absence of PRL (Fig. 3 E and F), PRL stimulation routinely
increased FRET signal intensity of WT PRLR by a factor of 2- to
3-fold (Fig. 3 E and F). Because individual K→R mutation had
little effect on PRLR dimerization as revealed by coimmuno-
precipitation analysis (Fig. S3C), we examined PRLR with mul-
tiple K→Rmutations for FRET. Receptors with triple or multiple
K→R mutations reduced FRET signal intensity but retained in-
creased dimerization in response to PRL treatment (Fig. 3 E and
F). When all 15 acetylatable lysine sites were substituted with
arginine (K1–15R), however, FRET signal became undetectable
(Fig. 3 E and F). PRLR (K1–15R) also showed reduced di-
merization in coimmunoprecipitation experiments (Fig. 3G). In
contrast, when all 15 lysine sites were replaced with alanine (K1–
15A), PRLR became more sensitive in FRET signal induction
and protein-protein interaction (Fig. 3 E–G). A basal level of
receptor dimerization detected with different approaches here is
in agreement with the fact that a basal level of PRLR-CBP as-
sociation or a basal level of PRLR acetylation was visualized
under the conditions used.
STAT5b Dimerization Relies on the Family-Conserved Acetylation Site
Within the C-Terminal Region. STAT5 is the principal signaling
factor recruited by the PRLR cytoplasmic loop for activation. To
identify acetylation sites of STAT5, acetylated STAT5b proteins
were immunopuriﬁed from 293T cells overexpressing CBP and
analyzed with MS. Both MS and site-directed mutagenesis results
revealed that K694 and K701 within the SH2-dimerization do-
main and K359 within the DNA-binding domain were major
acetyl-lysine sites of STAT5b protein (Fig. 4 A and B). It is worth
noting that K694 and K701 sites could be independently acety-
lated and that STAT5b phosphorylation on Y699 was not a pre-
requisite for acetylation of these two adjacent lysine sites, as
reﬂected from the mass spectra. To conﬁrm endogenous STAT5b
acetylation induction, polyclonal antibodies were prepared for
K359-, K694-, and K701-acetylated STAT5b (Fig. S1E). Using
these speciﬁc antibodies, we clearly detected STAT5b acetylation
induction on these three lysine sites by PRL in T47D cells, albeit
with different patterns (Fig. 4C). STAT5b and PRLR acetylation
share common features: (i) depletion of CBP with siRNA largely
abolished STAT5b acetylation in response to PRL treatment in
T47D cells (Fig. 4D); (ii) STAT5b was preferentially acetylated
by CBP when compared with other HAT in 293T cells (Fig. S4A);
and (iii) pretreatment of the cells with NAM and, to a lesser
extent, TSA enhanced CBP-mediated STAT5b acetylation (Fig.
S4B). K694 and K701 of STAT5b are located in close proximity
to the interface of the STAT5b dimer (Fig. S4C) (10). To test
whether acetylation affects STAT5b dimerization, we cotrans-
fected Myc-tagged and HA-tagged STAT5b in STAT5-null PC3
cells for STAT5/STAT5 coimmunoprecipitation analysis. PC3
is a prostate cancer cell line with deletion mutations of three
STAT (i.e., stat3, stat5a, stat5b) genes (11). STAT5b with K694R
substitution or, to a lesser extent, K701R substitution impaired
STAT5b dimerization, whereas STAT5b with K359R substitution
showed a minimal but repeatable positive effect on STAT5b di-
merization (Fig. 4E and Fig. S4D). We used PC3 to test STAT5b
acetylation on transcription. STAT5b with K701R substitution
showed a minor effect on STAT5b transcriptional activation,
whereas STAT5b with K359R or K694R substitution or K694/
K701R double mutation apparently attenuated STAT5b tran-
scriptional activity, as assayed by luciferase induction driven by the
Lactogenic Hormone Responsive Element (pLHRE) promoter
(Fig. 4F). These results indicate that acetylation on multiple lysine
sites within different domains coordinately regulates transcrip-
tionally active STAT5b dimer formation.
In lieu of the signiﬁcance of cytokine receptor dimerization for
signal transduction, we examined STAT5b recruitment and acti-
vation by PRLR K1–15R. Although PRLR K1–15R mutant still
associated with STAT5b, Y699 phosphorylation and K694 acet-
ylation were abolished (Fig. 4G). BothWT PRLR and PRLRK1–
15R mutant recruited JAK2 constitutively and responded to li-
gand stimulation for JAK2 autophosphorylation (Fig. 4H). These
ﬁndings agreed with reports that cytokine receptor dimerization
is needed for STAT activation but not for STAT or JAK docking
(12–14). None of the single PRLR K→R mutants impaired
STAT5b recruitment and STAT5b phosphorylation onY699 (Fig.
S4 E and F). The fact that both WT PRLR and PRLR K1–15R
exhibited similar ligand-binding efﬁciency in FACS analysis (Fig.
S4G) suggests that PRLR with multiple K→R substitution in its
cytoplasmic loop did not alter its extracellular domain activity in
ligand recruitment. When PRLR downstream STAT5-dependent
reporter activity was analyzed, PRLR largely abolished tran-
scriptional activation only when all acetylated lysines were
replaced with arginines (i.e., K1–15R) (Fig. 4I Left). In contrast,
PRLRK1–15Amutation showed an increased response to PRL in
terms of STAT5-dependent reporter activation (Fig. 4I Left).
PRLR-T539A mutant inhibited STAT5b activation, whereas
PRLR-T539Dmutant showed normal STAT5b activation (Fig. 4I
Left), supporting the ﬁnding that CBP can associate with PRLR
on phospho-T539, leading to both PRLR and STAT5b activation.
The opposite effects of CBP and SIRT2 on PRLR in STAT5b-
dependent transcriptional activation were obvious, as revealed
either by overexpression of ectopic CBP or SIRT2 gene or by
depletion of endogenous CBP or SIRT2 in 293T cells (Fig. 4I
Right). These results clearly demonstrate that CBP-catalyzed
acetylation plays a critical role from PRLR to its downstream
STAT5b activation.
Discussion
Dimerization has evolved as a general mechanism to bestow
cellular proteins with functions from signal transduction to tran-
scriptional activation (15, 16). Here, we demonstrate that PRLR
undergoes dynamic cytoplasmic loop dimerization that is inde-
pendent of extracellular dimerization but tightly regulated by
acetylation in cells; cytoplasmic loop-dimerized PRLR then
activates STAT5b, which is also acetylated by CBP and undergoes
acetylation-dependent homodimerization (Fig. 5). Among type I
cytokine receptors, PRLR has a long cytoplasmic loop, which is
lysine-rich (29 lysines vs. 5 arginines). Although a longer loop can
recruit more signaling molecules for activation, it becomes more
difﬁcult to undergo homodimerization, presumably because it
carries more positive-charged residues. Acetylation provides such
a nuance modulation by neutralizing the positive charges along
the loop, leading to close proximity within multiple regions. This
is most likely a common mechanism shared among type I cytokine
receptors because different type I cytokine receptors, including
erythropoietin receptor (EPOR), have all been found to undergo
acetylation-dependent homodimerization. For EGF receptor
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(EGFR) dimer, the intrinsic kinase domains of the twomonomers
have to be brought close enough to phosphorylate each other (5).
Although cytokine receptors recruit JAK and STAT constitu-
tively (2), acetylation brings two receptor loops into close prox-
imity, a step required for STAT activation, which is quite similar
to EGFR dimer autophosphorylation.
The basal level of cytoplasmic CBP could be responsible for
PRLR activation initiation, followed by continuous CBP supply
from nuclei. CBP activation by cytokine treatment is a receptor
dimerization-independent event (i.e., CBP nuclear export, CBP
cytokine receptor association, CBP-mediated cytokine receptor
acetylation). Although the mechanism responsible for CBP nu-
clear exportation on PRL treatment remains unclear, JAK ty-
rosine kinase activity is unlikely involved in CBP cytoplasmic
accumulation, because JAK2 depletion showed no effect on this
event. Although the bromodomain of CBP can provide a modu-
lar interaction with acetylated lysines (17), PRLR interacts with
CBP within the N-terminal domain (amino acids 1–460), where
NLS1 resides, and the C-terminal domain. Type I cytokine re-
ceptor acetylation by CBP appears to be indispensable for re-
ceptor activation and reﬂects dynamic conversion of the receptor
cytoplasmic loop’s proximity-independent signaling event into the
dependent one. CBP propagates acetylation from the membrane-
proximal region to the membrane-distal region. This indicates that
CBP may either interact with PRLR within multiple regions or
slide along the loop to acetylate multiple sites of the loop as well
as STAT proteins recruited by the loop.
It becomes clearer now that different STATmembers activated
by cytokines can be acetylated by CBP/p300 on multiple sites
within different domains. Surprisingly enough, the only conserved
acetylation site among STAT members is that of the SH2-
dimerization domain, which resides in front of the family-con-
served phosphotyrosine site. Cytokine-activated STAT switches
from transcriptionally inactive dimer via protein interaction
within the β-barrel DNA-binding domain into transcriptionally
active dimer via protein interaction within the C-terminal SH2
dimerization domain (18, 19). In cytokine-activated STAT1,
STAT4, and STAT6, the C-terminal SH2 dimerization domain-
conserved lysine is acetylated and plays a prominent role in their
homodimerization. Lacking this lysine in front of Y705, STAT3 is
preferentially acetylated on K685, which resides on the external
surface of the SH2 domain to form hydrogen bonds with two
phenylalanine residues of the hydrophobic core of the SH2 do-
main (20). Acetylation on K685 disrupts the hydrogen bonds,
leading to a conformational change necessary for active STAT3
dimer formation (21).
Hedgehog-induced receptor cytoplasmic domain phosphoryla-
tion creates a local negatively charged environment and induces a
conformational switch and dimerization in a seven-transmembrane
receptor protein (22). Likewise, acetylation creates a local envi-
ronment that is less positively charged for protein contact. Thus,
acetylation and deacetylation may provide amore general rheostat-
like function than serine phosphorylation does for transmembrane
receptors, regardless of the loop length, to undergo dimerization
and dedimerization during intracellular signal transduction.
Materials and Methods
Plasmids, Antibodies, and Cell Culture. Plasmids, antibodies, and cell culture
are discussed in SI Materials and Methods.
MS Analysis of Acetylated Lysine Sites. PRLR or STAT5b proteins, immuno-
precipitated from 293T cells transfected with PRLR or STAT5b alongwith CBP,
were resolved by 10% (w/v) SDS/PAGE and visualized by Coomassie blue
staining. The bands of PRLR and STAT5b (1–2 mg) were excised and sub-
jected to MS analysis provided by the Taplin Biological Mass Spectrometry
Facility at Harvard Medical School. MS analysis of other acetylated lysine
sites is discussed in SI Materials and Methods.
Immunoprecipitation and Western Blot Analysis, Luciferase Reporter Analysis,
siRNA Knockdown, in Vitro Acetylation Assay, and Flow Cytometry Analysis.
These processes are discussed in SI Materials and Methods.
FRET Assay. Photobleaching FRET imaging was conducted with a Nikon Eclipse
TE2000-U microscope using a 60× oil objective lens coupled to a CoolSNAP HQ
CCD camera (Roper Scientiﬁc). All imaging ﬁlters were from Chroma. They
were YFP (HQ500/20×, Q515LP, HQ535/30M), CFP (D436/20×, 455DCLP, D480/
40M), and YFP Photobleach (D535/50×, dichroic full mirror, metal slug). The
spectrally corrected FRET efﬁciency was calculated according to the published
protocol (23).
ACKNOWLEDGMENTS. We thank T. Welte (University of Texas Medical
Branch, Galveston, TX) for STAT5b cDNA construct, P. S. Rotwein for pLHRE-
luciferase reporter construct, T. P. Yao (Duke University, Durham, NC) for
HA-tagged and Myc-tagged mouse CBP cDNA constructs, D. M. Heery (Univer-
sity of Nottingham, UK) for CFP-mouse CBP cDNA construct, X. J. Yang (McGill
University Health Center, Canada) for some GST-CBP domain constructs, and
E. Seto (H. Lee Mofﬁtt Cancer Center and Research Institute, Tampa, FL) for
HDAC6 and HDAC3 cDNA constructs. We thank K. Heﬂin and X. L. Liu for
technical assistance; and our colleagues A. Ayala, J. Marshall, R. Page, and
J. S. Reichner for discussion and critical reading of this manuscript. This work
was supported by funds from the National Institutes of Health (to Y.E.C.).
1. Ihle JN, Kerr IM (1995) Jaks and Stats in signaling by the cytokine receptor
superfamily. Trends Genet 11:69–74.
2. Constantinescu SN, Huang LJ, Nam H, Lodish HF (2001) The erythropoietin receptor
cytosolic juxtamembrane domain contains an essential, precisely oriented, hydro-
phobic motif. Mol Cell 7:377–385.
3. MuthukumaranG,KotenkoS,Donnelly R, Ihle JN, PestkaS (1997)Chimeric erythropoietin-
interferon gamma receptors reveal differences in functional architecture of intracellular
domains for signal transduction. J Biol Chem 272:4993–4999.
4. Gadd SL, Clevenger CV (2006) Ligand-independent dimerization of the human
prolactin receptor isoforms: Functional implications. Mol Endocrinol 20:2734–2746.
5. Zhang X, Gureasko J, Shen K, Cole PA, Kuriyan J (2006) An allosteric mechanism for
activation of the kinasedomain of epidermal growth factor receptor.Cell 125:1137–1149.
6. Cohen HY, et al. (2004) Acetylation of the C terminus of Ku70 by CBP and PCAF
controls Bax-mediated apoptosis. Mol Cell 13:627–638.
7. Tang XL, et al. (2007) Acetylation-dependent signal transduction for type I interferon
receptor. Cell 131:93–105.
8. Biener E, et al. (2003) Ovine placental lactogen-induced heterodimerization of ovine
growth hormone and prolactin receptors in living cells is demonstrated by
ﬂuorescence resonance energy transfer microscopy and leads to prolonged
phosphorylation of signal transducer and activator of transcription (STAT)1 and
STAT3. Endocrinology 144:3532–3540.
9. Perrot-Applanat M, Gualillo O, Buteau H, Edery M, Kelly PA (1997) Internalization of
prolactin receptor and prolactin in transfected cells does not involve nuclear
translocation. J Cell Sci 110:1123–1132.
10. Neculai D, et al. (2005) Structure of the unphosphorylated STAT5a dimer. J Biol Chem
280:40782–40787.
11. Clark J, et al. (2003) Genome-wide screening for complete genetic loss in prostate
cancer by comparative hybridization onto cDNA microarrays. Oncogene 22:
1247–1252.
12. Klingmüller U, Bergelson S, Hsiao JG, Lodish HF (1996) Multiple tyrosine residues in
the cytosolic domain of the erythropoietin receptor promote activation of STAT5.
Proc Natl Acad Sci USA 93:8324–8328.
13. Behncken SN, et al. (2000) Growth hormone (GH)-independent dimerization of GH
receptor by a leucine zipper results in constitutive activation. J Biol Chem 275:
17000–17007.
14. Lu X, Huang LJ, Lodish HF (2008) Dimerization by a cytokine receptor is necessary for
constitutive activation of JAK2V617F. J Biol Chem 283:5258–5266.
15. Weiss A, Schlessinger J (1998) Switching signals on or off by receptor dimerization.
Cell 94:277–280.
16. Amoutzias GD, Robertson DL, Van de Peer Y, Oliver SG (2008) Choose your partners:
Dimerization in eukaryotic transcription factors. Trends Biochem Sci 33:220–229.
17. Dhalluin C, et al. (1999) Structure and ligand of a histone acetyltransferase
bromodomain. Nature 399:491–496.
18. Mao X, et al. (2005) Structural bases of unphosphorylated STAT1 association and
receptor binding. Mol Cell 17:761–771.
19. Mertens C, et al. (2006) Dephosphorylation of phosphotyrosine on STAT1 dimers
requires extensive spatial reorientation of the monomers facilitated by the N-
terminal domain. Genes Dev 20:3372–3381.
20. Becker S, Groner B, Müller CW (1998) Three-dimensional structure of the Stat3β
homodimer bound to DNA. Nature 394:145–151.
21. Yuan ZL, Guan YJ, Chatterjee D, Chin YE (2005) Stat3 dimerization regulated by
reversible acetylation of a single lysine residue. Science 307:269–273.
22. Zhao Y, Tong C, Jiang J (2007) Hedgehog regulates smoothened activity by inducing
a conformational switch. Nature 450:252–258.
23. Miyawaki A, Tsien RY (2000) Monitoring protein conformations and interactions by
ﬂuorescence resonance energy transfer between mutants of green ﬂuorescent
protein. Methods Enzymol 327:472–500.
Ma et al. PNAS | November 9, 2010 | vol. 107 | no. 45 | 19319
CE
LL
BI
O
LO
G
Y
